Â¥
29.56
May 17
New Key Statistics Module, Z-Score and F-Score
SZSE:002294 Key Ratios
Market Cap ¥ M | 32,953.98 |
Enterprise Value ¥ M | 31,390.39 |
P/E(ttm) | 57.96 |
PE Ratio without NRI | 53.55 |
Forward PE Ratio | -- |
Price/Book | 4.01 |
Price/Sales | 9.24 |
Price/Free Cash Flow | 128.52 |
Price/Owner Earnings | 469.21 |
Payout Ratio % | 0.91 |
Revenue (TTM) ¥ M | 3,568.00 |
EPS (TTM) ¥ | 0.51 |
Beneish M-Score | -2.43 |
10-y EBITDA Growth Rate % | -5.90 |
5-y EBITDA Growth Rate % | -7.50 |
y-y EBITDA Growth Rate % | -9.40 |
EV-to-EBIT | 48.48 |
EV-to-EBITDA | 48.48 |
PEG | -- |
Shares Outstanding M | 1,114.82 |
Net Margin (%) | 15.95 |
Operating Margin % | 18.05 |
Pre-tax Margin (%) | 17.67 |
Quick Ratio | 3.75 |
Current Ratio | 4.32 |
ROA % (ttm) | 5.98 |
ROE % (ttm) | 7.10 |
ROIC % (ttm) | 8.58 |
Dividend Yield % | 1.69 |
Altman Z-Score | 16.36 |
SZSE:002294 Number of Guru Trades
SZSE:002294 Volume of Guru Trades
Gurus Latest Trades with SZSE:002294
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002294 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shenzhen Salubris Pharmaceuticals Co Ltd Insider Transactions
No Available Data